(S)-tert-Butyl (1-(5-bromopyridin-2-yl)ethyl)carbamate
98%
- Product Code: 234968
CAS:
915720-71-7
Molecular Weight: | 301.18 g./mol | Molecular Formula: | C₁₂H₁₇BrN₂O₂ |
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | Boiling Point: | 381.8±32.0°C | |
Density: | Storage Condition: | Room temperature, dry |
Product Description:
Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors. Its chiral structure makes it valuable for creating enantiomerically pure drugs, where the (S)-configuration is critical for biological activity. Commonly employed in medicinal chemistry for constructing pyridine-containing drug candidates, especially in oncology and inflammatory disease research. The tert-butyl carbamate (Boc) group allows for selective amine protection during multi-step syntheses, enabling controlled coupling reactions with other pharmacophores. Its bromine functionality provides a site for cross-coupling reactions such as Suzuki or Buchwald-Hartwig, facilitating rapid structural diversification in drug discovery programs.
Sizes / Availability / Pricing:
Size | Availability | Price | Quantity |
---|---|---|---|
50mg | 10-20 days | ฿4,030.00 |
+
-
|
250mg | 10-20 days | ฿12,170.00 |
+
-
|
(S)-tert-Butyl (1-(5-bromopyridin-2-yl)ethyl)carbamate
Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors. Its chiral structure makes it valuable for creating enantiomerically pure drugs, where the (S)-configuration is critical for biological activity. Commonly employed in medicinal chemistry for constructing pyridine-containing drug candidates, especially in oncology and inflammatory disease research. The tert-butyl carbamate (Boc) group allows for selective amine protection during multi-step syntheses, enabling controlled coupling reactions with other pharmacophores. Its bromine functionality provides a site for cross-coupling reactions such as Suzuki or Buchwald-Hartwig, facilitating rapid structural diversification in drug discovery programs.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :